Newsmeme!
Discover News you didn't know existed
Tideland News Writer When former Swansboro resident Tina Bell Midgett opened her home to a baby with special needs all those years ago, she could not have had any idea what would grow from the gesture.
Transforming human liver cells into something like the pancreatic beta cells that produce insulin could result in a one-off treatment for diabetes
You can shoot, snowboard, and conquer worlds, but talking in games has never convinced anyone. Chatbots could change all that You're walking through a virtual world, beautifully rendered with cutting-edge graphics. Birds flutter overhead, and sunlight glints off a nearby babbling brook. The sense of immersion is immense. But try talking to anyone and the illusion is shattered. Must conversation ...
More and more, people are making the switch to organic and natural personal care items. Swanson Vitamins adds Alba, Avalon Organics and Abra Therapeutics to their inventory.
Life in the rodeo is tough, but Hall of Fame cowboy Charles Sampson knows he's had it easy when he watches his friend Maddie Olson. Olson, who uses a wheelchair, is among 13 entrants competing Wednesday in the 13th annual Special Rodeo at the ProRodeo Hall of Fame.
The Pioneers Park Nature Center hasn’t charged an admission fee in 40 years, but that could change soon. Lincoln Mayor Chris Beutler’s proposed municipal budget is balanced in part through fee increases, and the Parks & Recreation Department has a slew of them.
Severe acute malnutrition affects 13 million children worldwide and causes 1—2 million deaths every year. Our aim was to assess the clinical and nutritional efficacy of a probiotic and prebiotic functional food for the treatment of severe acute malnutrition in a HIV-prevalent setting.
Two prime waterfront sites in Waiwera, with future development potential, are up for mortgagee tender. One encompasses 1.7781 hectares of land with a high density residential zoning that currently houses the Waiwera Holiday Park. The other is a ...
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 9, 2009) - Allon Therapeutics Inc. (TSX:NPC) today released top-line results from a Phase IIa clinical trial showing that the Company's lead neuroprotective drug candidate, davunetide intranasal (AL-108), has a positive impact on the ability of schizophrenia patients to carry out important activities in their daily lives. Allon said statistically ...
VANCOUVER, BRITISH COLUMBIA-- - Allon Therapeutics Inc. today released top-line results from a Phase IIa clinical trial showing that the Company's lead neuroprotective drug candidate, davunetide intranasal , has a positive impact on the ability of schizophrenia patients to carry out important activities in their daily lives.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |